☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
fda
New Drug Designations - August 2024
September 25, 2024
FDA Overview and Its Role in Transforming the Pharmaceutical Landscape
August 30, 2024
New Drug Designations - September 2023
October 16, 2023
FDA Launches a Pilot Program to Regulate the Safety Standards Associated with In vitro Diagnostic Tests to Identify Cancer Biomark...
June 23, 2023
Alnylam’s Amvuttra (vutrisiran) Receives the US FDA’s Approval for Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
June 14, 2022
Glenmark’s Ryaltris Nasal Spray Receives the US FDA’s Approval for the Treatment of Seasonal Allergic Rhinitis
January 14, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.